Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study.
An increased risk of mortality in patients with hyperuricemia has been reported. We examined (1) the risk of all-cause and cardiovascular disease (CVD) mortality in untreated hyperuricemic patients who did not receive urate-lowering therapy (ULT), and (2) the impact of ULT on mortality risk in patie...
Main Authors: | Jiunn-Horng Chen, Joung-Liang Lan, Chi-Fung Cheng, Wen-Miin Liang, Hsiao-Yi Lin, Gregory J Tsay, Wen-Ting Yeh, Wen-Harn Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4684295?pdf=render |
Similar Items
-
Variation in serum urate levels in the absence of gout and urate lowering therapy
by: Andrew Shaffer, et al.
Published: (2021-09-01) -
Evaluating the urate-lowering effects of different microbial fermented extracts in hyperuricemic models accompanied with a safety study
by: Rong-Jane Chen, et al.
Published: (2017-07-01) -
Treatment approaches and adherence to urate-lowering therapy for patients with gout
by: Aung T, et al.
Published: (2017-04-01) -
The effect of acute gout on inflammatory markers in hyperuricemic patients
by: Kopke, Amy
Published: (2013) -
Behavioral Characteristics of Gout Patients and Their Impact on the Results of Urate Lowering Therapy
by: J. Chen, et al.
Published: (2021-04-01)